短乳杆菌与植物乳杆菌的发酵特性

【背景】目前对于酸菜发酵的研究主要关注点是植物乳杆菌(Lactobacillus plantarum),有关短乳杆菌(Lactobacillus brevis)在酸菜方面的研究报道很少。【目的】为了挖掘短乳杆菌的发酵性能并开发酸菜发酵剂,将2株短乳杆菌分别与1株植物乳杆菌进行组合并发酵酸菜,分析短乳杆菌对酸菜发酵品质的影响。【方法】分别测定短乳杆菌与植物乳杆菌的单菌株生长产酸性能、耐酸性及亚硝酸盐降解力,并将两菌种组合后发酵酸菜,分析1-7d内酸度、乳酸菌活菌数、亚硝酸盐含量及酸菜质构特性的变化趋势。【结果】相较于短乳杆菌Lb-9-2,短乳杆菌Lb-5-3的生长和产酸速率较慢、酸耐受力较弱,但其亚硝酸盐降解力较强。两株短乳杆菌分别与植物乳杆菌Lp-9-1组合后产酸力显著增强,并在3 d时达到最低pH值(约3.10);植物乳杆菌Lp-9-1的添加使酸菜中总体乳酸菌生长延迟,在5 d时达到最高活菌数;组合菌种的样品中亚硝酸盐含量在1-7 d内变化较为平缓,前5天内两个组合之间差异不显著;接种乳酸菌会降低酸菜硬度和弹性,发酵3d时Lb-5-3/Lp-9-1组合的硬度最大,感官评价得分最高。【...     

乳杆菌Lactobacillus sp.lxp发酵高产L-乳酸研究

筛选得到一株乳杆菌Laetobaeillus sp．,进行发酵生产高浓度L-乳酸的研究。考察了种龄、接种量、温度和不同pH调节剂对乳酸发酵的影响。结果表明：最佳种子培养时间为15h;最佳接种量为15％;最适培养温度为42℃;与氨水和氢氧化钠相比,碳酸钙更适于作为发酵过程的pH调节刺;以葡萄糖为碳源,添加豆粕水解液和玉米浆作为辅料,2L罐培养120h,L-乳酸质量浓度可达202 g/L,糖转化率91．3％,L-乳酸占发酵液中总酸含量98％以上。     

植物乳杆菌Lp-2的高密度发酵

高密度培养植物乳杆菌是制作其发酵剂的重要环节。首先,研究了不同的溶氧和pH对植物乳杆菌的分批发酵的影响。在分批发酵的基础上,为进一步提高发酵液中的菌体浓度,进行了补料分批发酵实验。最终通过对蔗糖反馈补料发酵试验对比改造获得了pH反馈补料发酵工艺。此发酵补料工艺可以控制蔗糖残糖量始终处于较低的水平,因此获得了最高的菌体产量。菌体干重达到13.56g/L,较分批培养提高90.05%。     

鼠李糖乳杆菌LV108及其发酵乳免疫调节作用的比较

目的 探讨鼠李糖乳杆菌LV108及其发酵乳对免疫抑制小鼠免疫功能的调节作用。 方法 将BALB/c小鼠随机分为5组,每组10只,即空白组(正常小鼠)、模型组(免疫抑制小鼠)、药物组(免疫抑制小鼠食物中添加左旋咪唑)、LV108菌悬液组(免疫抑制小鼠食物中添加LV108菌悬液)和LV108发酵乳组(免疫抑制小鼠食物中添加LV108发酵乳),除空白组外其余组构建免疫抑制小鼠模型。干预4周后,分别测定各组小鼠体质量和脏器指数,血清中白细胞介素2(IL2)、肿瘤坏死因子α(TNFα)和免疫球蛋白G(IgG)含量,血清溶血素含量、耳肿胀度和肝、脾巨噬细胞吞噬能力。 结果 相比模型组,LV108菌悬液组和LV108发酵乳组小鼠体质量增长速度、脏器指数、血清IL2与IgG水平、血清溶血值、耳肿胀度和巨噬细胞吞噬能力显著升高(均P结论 LV108菌体及发酵乳对免疫抑制小鼠具备较全面的免疫调节作用,均可提高小鼠的自身免疫力;LV108发酵乳对小鼠的免疫调节作用强于LV108菌体。     

弱后酸化瑞士乳杆菌的筛选及发酵特性研究

[目的]在大健康背景下,发酵乳凭借其优良的营养和保健功能备受青睐.后酸化是发酵乳在贮存、运输和销售等过程中活性乳酸菌继续代谢产酸导致的,严重影响产品的感官品质,降低菌株的存活率.本文通过筛选弱后酸化的瑞士乳杆菌,改善发酵乳的后酸化问题.[方法]本研究以瑞士乳杆菌L551为出发菌株,硫酸新霉素为筛选压力,筛选弱后酸化的瑞...     

不同发酵条件对乳杆菌O-2菌株代谢产物的影响

目的:研究乳杆菌(Lactobacillus acidophilus sp.)O-2菌株生长和积累类细菌素所需的营养和温度条件.方法:采用分段控温发酵法,即在发酵后期,改变温度继续发酵;以发酵液抑菌圈直径为指标对发酵的营养和温度条件进行筛选.结果:后期32 ℃控温发酵有利于类细菌素积累,优化后的4号配方,发酵液菌数高达8.2×1010个/ml(细菌计数器法),抑菌圈直径最大,达到8.8 mm.结论:利用4号配方进行分段控温发酵能有效地促进O-2菌株的生长繁殖和积累类细菌素.     

芽孢乳杆菌发酵葡萄糖制备D(-)-乳酸的研究

在国内首次报道了发酵法制备D(-)-乳酸,采用芽孢乳杆菌(Sporolactobacillus sp．)从葡萄糖发酵制备D-乳酸。该发酵为微需氧,发酵培养基组成(g/L):葡萄糖60,酵母膏6,玉米浆5,NH4NO3l,麸皮2,NaH2PO4 4,CaCO340。发酵液的初始pH为7．0.在最佳条件下,37℃发酵72h可产40．7g/L的D-乳酸,葡萄糖转化率67．83％。通过离子配位色谱分析,产物的D-乳酸光学纯度为96．04％e．e．。     

植物乳杆菌R260产细菌素发酵条件的研究

目的 获取植物乳杆菌R260产细菌素的最佳发酵条件.方法用琼脂扩散法测定发酵液对苏云金芽胞杆菌的抑菌效价.结果 产细菌素的最佳培养基是MRS培养基,最适起始Ph为6.5,最适接种量和接种种龄分别为3%和12 h,产细菌素最适发酵温度和时间分别为30℃和20 h：细菌素在对数期开始产生,稳定期产量达到最大值.结论 通过优化发酵条件提高了细菌素的产量,达1656 IU/ml.     

藏北地区传统发酵乳中乳杆菌的多样性分析

摘要：【目的】针对藏北地区的乳杆菌来源及种属,对其多态性进行研究。【方法】采用ERIC-PCR技术和NTSYS-pc2.1软件对从藏北地区牧民家庭制作的发酵乳制品中分离出的77株乳杆菌进行多样性分析。【结果】ERIC-PCR扩增出的条带清晰,重复性好,多态性高。聚类分析表明,在0.73的水平上,77株乳杆菌共分为4大类群：干酪乳杆菌群A1、发酵乳杆菌群A2,瑞士乳杆菌群A3和植物乳杆菌群A4。其中,干酪乳杆菌群A1和发酵乳杆菌群A2分别占供试乳杆菌的35.06%和61.04%,为优势菌群。进一步对优势菌群     

对德氏乳杆菌DM8909菌株的发酵工艺研究

德氏乳杆菌 DM890 9菌株是大连医科大学微生态学研究所分离驯化的一株兼性厌氧菌 ,主要用于防治非特异性阴道炎等妇科疾病。本实验通过对德氏乳杆菌 DM890 9菌株进行摇瓶、小型全自动发酵罐和 5 0 0 L发酵罐发酵工艺学研究 ,考察其发酵工艺中试条件。现将研究结果报告如下 :1　材料与方法1.1　菌种　本研究所使用的菌种德氏乳杆菌 DM890 9(L actobacillus debrueckii subsp.lactis)由大连医科大学微生态学研究所提供。1.2　培养基　摇瓶种子培养基、小罐发酵培养基及大罐发酵培养基均采用 L BS培养基。1.3　培养方法1.3.1　摇瓶培养　…     

火龙果汁发酵饮品的研制

火龙果不但营养丰富而且具有一定的保健功能。本试验以新鲜的红皮白肉型火龙果果实的榨汁为原料,分别对发酵工艺条件、蔗糖添加量、柠檬酸用量、稳定剂用量等条件进行了研究,通过单因素试验和正交试验,得到火龙果汁发酵饮料的最佳工艺配方。采用该工艺配方制备的发酵饮料澄清透明,具有清新的果香和淡淡的醇香,酸甜可口,口感顺滑。     

Selective enumeration of Lactobacillus casei from yogurts and fermented milk drinks

A selective medium (LC agar) was developed for enumeration of Lactobacillus casei populations from commercial yogurts and fermented milk drinks that may contain strains of yogurt bacteria (Streptococcus thermophilus and Lactobacillus delbrueckii ssp. bulgaricus), probiotic bacteria (Lactobacillus acidophilus and bifidobacteria) and L. casei. Appropriate dilutions were pour-plated in specially formulated LC agar acidified to pH 5.1 and the plates incubated at 27°C for 72 to 96 h under anaerobic conditions. Growth of S. thermophilus was prevented by adjusting pH to 5.1. L. delbrueckii ssp. bulgaricus did not ferment ribose as the carbon source, as a result the organisms did not form colonies. L. acidophilus formed colonies on MRS-ribose agar; however, this organism did not grow in the specially formulated LC agar containing ribose. Similarly, Bifidobacterium spp. did not form colonies in LC agar. L. casei formed colonies on LC agar. © Rapid Science Ltd. 1998     

褐色乳酸菌饮料稳定体系的优化

为探究褐色乳酸菌饮料的体系稳定性,通过单因素和正交试验证明了葡萄糖添加量、褐变时间和发酵时间对乳酸菌饮料稳定性的影响较小;而基料添加量(蛋白质含量)、饮料pH和均质压力对稳定性的影响较大。获得褐色乳酸菌饮料最优稳定体系参数为：葡萄糖添加量80 g,褐变时间2 h,发酵时间72 h,基料添加量200 g,饮料pH 3.7,均质压力200 MPa。研究结果不仅优化了褐色乳酸菌饮料的制作工艺,而且降低了稳定剂的添加量,降低了生产成本。     

活性乳酸菌饮料对人体肠道菌群影响的研究

目的 探讨一种活性乳酸菌饮料对人体肠道菌群的影响作用.方法 采用卫生部《保健食品检验与评价技术规范》调节肠道菌群功能检验方法进行检验.结果 试食组试验前后自身比较：肠道内双歧杆菌、乳杆菌数量明显增加（P＜0.01）,肠球菌数量增加（P＜0.05）,产气荚膜梭菌数量明显减少（P＜0.01）,肠杆菌和拟杆菌无明显变化;试验后对照组与试食组组间比较：双歧杆菌数量明显增加（P＜0.01）,乳杆菌的数量增加（P＜0.05）,肠杆菌、肠球菌、产气荚膜梭菌和拟杆菌无明显变化.结论 活性乳酸菌饮料具有调节人体肠道菌群、改善肠道内环境的作用.     

Preliminary human study for possible alteration of serum immunoglobulin E production in perennial allergic rhinitis with fermented milk prepared with Lactobacillus gasseri TMC0356

The fermented milk prepared with Lactobacillus gasseri TMC0356 was administered at 200 ml per day for 4 weeks to 15 subjects with high serum IgE levels and perennial allergic rhinitis. The serum total IgE concentration was significantly reduced after 28 days' exposure to the fermented milk (P <0.05) compared to that before the intervention. The serum IgE specific to Acari and those to Japanese cedar pollen also significantly declined (P <0.05). T helper 1 (Th1) cells in the composition of their peripheral blood mononuclear cells (PBMCs) significantly increased after 14 days (P <0.01) and after 28 days (P <0.05). These results suggest that the fermented milk prepared with L. gasseri TMC0356 may alter serum IgE concentration, at least partly by enhancement of Th1 immune responses of the subjects with high concentration of serum IgE. However, further studies are still necessary to know the underlying mechanisms by which the tested fermented milk could influence the host immunity.     

Manufacturing of fermented goat milk with a mixed starter culture of Bifidobacterium animalis and Lactobacillus acidophilus in a controlled bioreactor

AIMS: This work was undertaken to study the feasibility and the characteristics of a fermented product made of goat milk, using a mixed starter culture of Bifidobacterium animalis and Lactobacillus acidophilus under controlled conditions, and to determine their survival in the fermented milk during refrigerated storage. METHODS AND RESULTS: Goat milk was inoculated with Lact. acidophilus and Bif. animalis mixed starter, fermented in a glass bioreactor with controlled temperature (37 degrees C) and anaerobiosis, and monitored for growth and acidification. The fermented milk was then stored for 10 days under refrigeration, and monitored daily for starter microflora survival and pH changes. Lact. acidophilus viable counts reached a maximum of 7.1 x 10(8) colony-forming units (CFU) ml(-1), and Bif. animalis a maximum of 6.3 x 10(7) CFU ml(-1) by 20 h of fermentation. During refrigerated storage, both strains exhibited a good survival, with viable numbers remaining essentially constant throughout the experiment, whereas the pH of the fermented milk dropped slightly. CONCLUSIONS: Mixed cultures of Bif. animalis and Lact. acidophilus may be used to produce fermented goat milk with high counts of both probiotic strains. SIGNIFICANCE AND IMPACT OF THE STUDY: Goat milk fermented with Bif. animalis and Lact. acidophilus can be manufactured as an alternative probiotic dairy product.     

In vitro growth control of selected pathogens by Lactobacillus acidophilus- and Lactobacillus casei-fermented milk

AIMS: Food-borne pathogen inhibition was tested in the presence of a mixture of Lactobacillus acidophilus and Lactobacillus casei during fermentation under controlled pH conditions. METHODS AND RESULTS: The growth of Escherichia coli O157:H7, Salmonella serotype Typhimurium, Staphylococcus aureus, Listeria innocua, Enterococcus faecium and Enterococcus faecalis was evaluated for 48 h at 37 degrees C. In the presence of the lactic acid bacteria (LAB), an increase of the generation time was observed for all the gram-positive bacteria evaluated. Staphylococcus aureus was the most sensitive strain showing an increase of the generation time by 210%. However, for all the gram-negative bacteria evaluated, no inhibition occurred after 8 h of fermentation. The soluble portion of Lact. acidophilus- and Lact. casei-fermented milk was recuperated and tested for its antimicrobial activity. Listeria innocua and Staph. aureus were the most sensitive to the presence of fermented milk supernatant showing an inhibition of 85.9% and 84.7%, respectively. This soluble fraction was neutralized to eliminate the antimicrobial effect of the organic acids produced; the most sensitive strains were L. innocua and E. coli O157:H7 showing an inhibition of 65.9% and 61.9%, respectively. Finally, the soluble fraction was neutralized and irradiated at 45 kGy using a (60)Co source to eliminate the possible antimicrobial effect of both organic acids and bacteriocin-like substances. Enterococcus faecalis, E. coli O157:H7 and Staph. aureus were the most affected bacteria by this fraction, showing 39.1, 32 and 31.2% inhibition, respectively. CONCLUSIONS: The results obtained in this study suggest the implication of both organic acids and bacteriocin-like inhibitory substances in the antimicrobial activity observed in the soluble fraction of the probiotic preparation. SIGNIFICANCE AND IMPACT OF THE STUDY: This study revealed the antimicrobial mechanisms of action of Lact. acidophilus- and Lact. casei-fermented milk used to prevent antibiotic-associated diarrhoea.     

Effect of milk fermented with a Lactobacillus helveticus R389(+) proteolytic strain on the immune system and on the growth of 4T1 breast cancer cells in mice

Previous studies on a murine model have demonstrated that the administration of Lactobacillus helveticus and Lactobacillus casei inhibits the development of fibrosarcoma and colon carcinoma, respectively. The aim of this work was to study the beneficial effects of the consumption of milk fermented by L. helveticus on a murine model for mammary carcinoma. Female BALB/c mice were challenged by a single subcutaneous injection of tumoral cells (American Type Culture Collection 4T1) in the left mammary gland. Prior to tumour injection, mice were fed for two, five or seven consecutive days with fermented milk. The following factors were monitored for 2 months: rate of tumour development, histological studies, apoptosis, phagocytic index, peritoneal macrophages, determination of beta-glucuronidase enzyme in peritoneal macrophages, determination of gamma-interferon (INFgamma) and tumour necrosis factor-alpha (TNF-alpha) in blood serum, determination of CD4+, CD8+, interleukin-6 (IL-6), IL-10, TNF-alpha and INFgamma by immunoperoxidase, and measurement of beta-glucuronidase activity in intestinal fluid. The administration of L. helveticus delayed the development of the tumour in all cases, a 2- or 7-day feeding period being most effective. This work demonstrates that milk fermented with L. helveticus decreases the growth rate of mammary tumours. The effect was mediated by increased apoptosis and decreased production of pro-inflammatory cytokines, in particular IL-6, implicated in oestrogen synthesis.